Related Experiment Videos
Virus-host cell interactions in human immunodeficiency virus infections
S Gartner1, K Ohashi, M Popovic
1Primate Research Institute, New Mexico State University, Holloman AFB 88330.
Advances in Experimental Medicine and Biology
|January 1, 1991
Summary
The Human Immunodeficiency Virus type 1 (HIV-1) isolate HTLV-IIIB exhibits unique biological behaviors, including infecting non-T cells and chimpanzee T cells. Its high CD4 receptor binding affinity may explain these distinct characteristics.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- The Human Immunodeficiency Virus type 1 (HIV-1) isolate HTLV-IIIB is widely utilized in research.
- Understanding the specific biological properties of viral isolates is crucial for accurate interpretation of study findings.
Purpose of the Study:
- To highlight the unique biological behaviors of the HTLV-IIIB isolate.
- To investigate the potential mechanisms underlying HTLV-IIIB's distinct infectivity and receptor binding.
- To provide evidence for CD4-mediated entry of HIV-1 into human monocyte/macrophages.
Main Methods:
- Comparative analysis of viral isolate infectivity across different cell types.
- Assessment of binding affinity to the CD4 receptor.
- In vitro studies demonstrating viral entry mechanisms.
Main Results:
- HTLV-IIIB demonstrates an expanded host cell range, infecting cells beyond T lymphocytes and mononuclear phagocytes.
- HTLV-IIIB exhibits enhanced infectivity in chimpanzee T cells.
- A greater binding affinity of HTLV-IIIB to the CD4 receptor molecule was observed.
- Evidence supports CD4-mediated entry of HIV-1 into normal human monocyte/macrophages.
Conclusions:
- The HTLV-IIIB isolate possesses unique biological characteristics, including broad cell tropism and specific receptor interactions.
- Findings underscore the importance of caution when generalizing results from HTLV-IIIB studies to other HIV-1 isolates.
- The study provides further evidence for the role of CD4 in HIV-1 cell entry, particularly in myeloid cells.